These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11572113)

  • 1. [Proliferation rate of small cell lung carcinoma. A cytomorphometric parameter with prognostic significance].
    Kayser G; Gunzenhäuser I; Becker HD; Herth F; Kayser K
    Pathologe; 2001 Sep; 22(5):326-32. PubMed ID: 11572113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of serum tumor markers in patients with lung cancer.
    Hatzakis KD; Froudarakis ME; Bouros D; Tzanakis N; Karkavitsas N; Siafakas NM
    Respiration; 2002; 69(1):25-9. PubMed ID: 11844959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC.
    Muley T; Dienemann H; Ebert W
    Anticancer Res; 2003; 23(5b):4085-93. PubMed ID: 14666606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-67 expression and prognosis for smokers with resected stage I non-small cell lung cancer.
    Haga Y; Hiroshima K; Iyoda A; Shibuya K; Shimamura F; Iizasa T; Fujisawa T; Ohwada H
    Ann Thorac Surg; 2003 Jun; 75(6):1727-32; discussion 1732-3. PubMed ID: 12822607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis.
    Gronowitz JS; Bergström R; Nôu E; Påhlman S; Brodin O; Nilsson S; Källander CF
    Cancer; 1990 Aug; 66(4):722-32. PubMed ID: 2167141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNM stage, immunohistology, syntactic structure analysis and survival in patients with small cell anaplastic carcinoma of the lung.
    Kayser K; Fitzer M; Bülzebruck H; Bosslet K; Drings P
    J Cancer Res Clin Oncol; 1987; 113(5):473-80. PubMed ID: 3040767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma: does the combined use of cytokeratin markers give any additional information?
    Nisman B; Lafair J; Heching N; Lyass O; Baras M; Peretz T; Barak V
    Cancer; 1998 May; 82(10):1850-9. PubMed ID: 9587116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.
    Jørgensen LG; Osterlind K; Genollá J; Gomm SA; Hernández JR; Johnson PW; Løber J; Splinter TA; Szturmowicz M
    Br J Cancer; 1996 Aug; 74(3):463-7. PubMed ID: 8695366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Elevated serum NSE level in locally advanced and metastatic NSCLC predispose to better response to chemotherapy but worse survival].
    Załeska M; Szturmowicz M; Zych J; Roszkowska-Sliz B; Demkow U; Langfort R; Roszkowski-Sliz K
    Pneumonol Alergol Pol; 2010; 78(1):14-20. PubMed ID: 20162514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
    Ando S; Suzuki M; Yamamoto N; Iida T; Kimura H
    Anticancer Res; 2004; 24(3b):1941-6. PubMed ID: 15274381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large cell carcinoma of the lung. Prognostic implications of histopathologic and immunohistochemical subtyping.
    Ishida T; Kaneko S; Tateishi M; Oka T; Mitsudomi T; Sugimachi K; Hara N; Ohta M
    Am J Clin Pathol; 1990 Feb; 93(2):176-82. PubMed ID: 2154087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive and prognostic value of preoperative serum tumor markers in resectable adenosqamous lung carcinoma.
    Zhi Q; Wang Y; Wang X; Yue D; Li K; Jiang R
    Oncotarget; 2016 Oct; 7(40):64798-64809. PubMed ID: 27623437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors of tumor response and prognostic factors of survival during lung cancer chemotherapy.
    Ray P; Quantin X; Grenìer J; Pujol JL
    Cancer Detect Prev; 1998; 22(4):293-304. PubMed ID: 9674872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis.
    Kawai T; Suzuki M; Kono S; Shinomiya N; Rokutanda M; Takagi K; Ogata T; Tamai S
    Cancer; 1994 Nov; 74(9):2468-75. PubMed ID: 7923002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer - a retrospective single institution analysis.
    Hermes A; Gatzemeier U; Waschki B; Reck M
    Respir Med; 2010 Dec; 104(12):1937-42. PubMed ID: 20719490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment serum lactate dehydrogenase as additional staging parameter in patients with small-cell lung carcinoma.
    Stokkel MP; van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
    J Cancer Res Clin Oncol; 1998; 124(3-4):215-9. PubMed ID: 9619749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implication of Ki-67 immunostaining in treating subclinical pleural cancer found at thoracotomy in lung cancer patients.
    Shiba M; Kakizawa K; Kohno H; Shibuya K; Yamakawa H; Hiroshima K; Fujisawa T
    Ann Thorac Surg; 2001 Jun; 71(6):1765-71. PubMed ID: 11426745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of Ki-67 immunostaining and symptoms in resected stage I and II non-small cell lung cancer.
    Mehdi SA; Etzell JE; Newman NB; Weidner N; Kohman LJ; Graziano SL
    Lung Cancer; 1998 May; 20(2):99-108. PubMed ID: 9711528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.